CD44 and endometrial cancer: Spadea et al. [223] evaluated the expression of CD44 isoforms and HA-internalisation efficacy in human dermal fibroblasts (HDFs) and cancer cell lines including prostate, thyroid, head and neck, breast, ovarian, pancreatic, colorectal and endometrial cancers.